Also includes a method for treating or improving a Syndrome, a disorder or disease, where the Syndrome, disorder or disease is rheumatoid arthritis or psoriasis. This includes, in addition, a method to modulate the activity of rorgt in a Mammal by administering a therapeutically effective amount of at least one Compound of claim 1.Claim 1: a compound of the formula (1), where: r u00b9 is pirrolilo, pirazolilo, imidazolilo, triazolilo, thiazolyl, piridilo, N - Oxide piridilo, pirazinilo, pirimidinilo, piridazilo, piperidinilo, quinazolinilo, cinolinilo, benzotiazolilo, indazolilo, tetrahidropiranilo, tetrahidrofu Ranilo, furanilo, phenyl, oxazolilo, isoxazolilo, tiofenilo, benzoxazolilo, bencimidazolilo, indolilo,Tiadiazolilo, oxadiazolilo or quinolinilo； where the piridilo, N - Oxide piridilo, pirazinilo, pirimidinilo, piridazilo, piperidinilo, quinazolinilo, cinolinilo, benzotiazolilo indazolilo, imidazolilo, phenyl, tiofenilo, benzoxazolilo, benzimidazolilo, indolilo, quinolinilo and pirazolilo are s Ustituidos optionally alkyl C (OR) c u2081 u208b u2084, c u208do u208enh u2082, alkyl C (OR) nhc u2081 u208b u2082, c u208do u208en u208d u2090 u2097q u1d58 u2071 u2097 u2092 u2082, c u2081 u208b u2082)Alkyl (or c u2081 u208b u2084 NHC), nhso u2082c u2081 u208b u2084 alkyl, alkyl c u2081 u208b u2084, cf u2083, ch u2082cf u2083, CL, F, - CN, oc u2081 u208b u2084 alkyl (alkyl, N - ( u2082 c u2081 u208b u2084), ch u2082) u2083och u2083, alkyl sc u2081 u208b u2084, Oh, co u2082h, alkyl co u2082c u2081 u208b u2084, c u208do u208ecf u2083, so u2082cf u2083, ocf u2083, ochf u2082, so u2082ch u2083, so u2082nh u2082, alq Uilo so u2082nhc u2081 u208b u2082, so u2082n (alkyl c u2081 u208b u2082 u2082), C (o) nhso u2082ch u2083,Or och u2082och u2083； and optionally are replaced with up to two additional substituents selected from the group consisting of independently c u2081 u208b u2082 sch u2083, CL, alkyl, alkyl oc u2081 u208b u2082, cf u2083, - CN, and F； and where the tri
